Global Dry Eye Drugs Market Research Report 2018

 Published: Aug-2018 |  Number of pages: 128 |

Description

Synopsis
This report studies the global Dry Eye Drugs market status and forecast, categorizes the global Dry Eye Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

In the last several years, global market of Dry Eye Drugs developed rapidly, with an average growth rate of 11.84% during 2013 to 2017. In 2017, global revenue of Dry Eye Drugs is nearly 37 Billion USD; the actual sales are about 390 Million Unit.

The major players in global Dry Eye Drugs market include

  • Allergan
  • Novartis Ag
  • Valeant Pharmaceuticals
  • Santen Pharma
  • Shire
  • Johnson & Johnson
  • United Laboratories
  • Senju Pharmaceutical
  • Jianfeng Group
  • Eusan Gmbh

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Dry Eye Drugs in these regions, from 2013 to 2025 (forecast), covering

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

On the basis of product, the Dry Eye Drugs market is primarily split into

  • Artificial Tears
  • Anti-inflammatory drugs
  • Other

On the basis on the end users/applications, this report covers

  • Hospital
  • Drug Stores
  • Online Pharmacies
Table of Content
Index

Table of Contents

1 Dry Eye Drugs Market Overview 1
1.1 Dry Eye Drugs Product Overview 1
1.2 Dry Eye Drugs Segment by Types 2
1.2.1 Global Dry Eye Drugs Sales Comparison by Types (2013-2025) 2
1.2.2 Global Dry Eye Drugs Sales Market Share by Types in 2017 2
1.2.3 Artificial Tears 3
1.2.4 Anti-inflammatory drugs 3
1.3 Global Dry Eye Drugs Segment by Applications 4
1.3.1 Global Dry Eye Drugs Sales Comparison by Applications (2013-2025) 4
1.3.2 Hospital 5
1.3.3 Drug Stores 5
1.3.4 Online Pharmacies 6
1.4 Global Dry Eye Drugs Market by Regions (2013-2025) 6
1.4.1 Global Dry Eye Drugs Market Size and Growth Rate Comparison by Regions (2013-2025) 6
1.4.2 North America Dry Eye Drugs Status and Prospect (2013-2025) 7
1.4.3 Europe Dry Eye Drugs Status and Prospect (2013-2025) 8
1.4.4 Asia-Pacific Dry Eye Drugs Status and Prospect (2013-2025) 9
1.4.5 South America Dry Eye Drugs Status and Prospect (2013-2025) 10
1.4.6 Middle East and Africa Dry Eye Drugs Status and Prospect (2013-2025) 11
1.5 Global Dry Eye Drugs Market Size (2013-2025) 12
1.5.1 Global Dry Eye Drugs Revenue Status and Outlook (2013-2025) 12
1.5.2 Global Dry Eye Drugs Sales Status and Outlook (2013-2025) 13
2 Global Dry Eye Drugs Market Competition by Manufacturers/Brand 14
2.1 Global Dry Eye Drugs Sales and Share by Manufacturers 14
2.2 Global Dry Eye Drugs Revenue and Share by Manufacturers (2017-2018) 16
2.3 Global Dry Eye Drugs Average Price by Manufacturers (2017-2018) 18
2.4 Manufacturers Dry Eye Drugs Headquarters and Established Date 19
2.5 Dry Eye Drugs Market Competitive Situation and Trends 20
2.5.1 Dry Eye Drugs Market Concentration Rate 20
2.5.2 Dry Eye Drugs Revenue Market Share of Top 3 and Top 5 Manufacturers 21
2.5.3 Mergers & Acquisitions, Expansion 21
3 Global Dry Eye Drugs Sales, Revenue by Regions (2013-2018) 23
3.1 Global Dry Eye Drugs Sales and Market Share by Regions (2013-2018) 23
3.2 Global Dry Eye Drugs Revenue and Market Share by Regions (2013-2018) 25
3.3 Global Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 27
3.4 North America Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 27
3.5 Europe Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 27
3.6 Asia-Pacific Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 28
3.7 South America Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 28
3.8 Middle East and Africa Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 28
4 Global Dry Eye Drugs Sales, Revenue, Price Trend by Types 29
4.1 Global Dry Eye Drugs Sales and Market Share by Types (2013-2018) 29
4.2 Global Dry Eye Drugs Revenue and Market Share by Types (2013-2018) 31
4.3 Global Dry Eye Drugs Price by Type (2013-2018) 32
4.4 Global Dry Eye Drugs Sales Growth by Type (2013-2018) 33
5 Global Dry Eye Drugs Market Analysis by Applications 34
5.1 Global Dry Eye Drugs Sales and Market Share by Applications (2013-2018) 34
5.2 Global Dry Eye Drugs Sales Growth Rate by Applications (2013-2018) 36
6 Analysis of Dry Eye Drugs Industry Key Manufacturers 37
6.1 Allergan 37
6.1.1 Company Profile 37
6.1.2 Product Information 38
6.1.3 Sales, Price, Cost, Profit, and Revenue 38
6.2 Novartis AG 39
6.2.1 Company Profile 39
6.2.2 Product Information 40
6.2.3 Sales, Price, Cost, Profit, and Revenue 40
6.3 Valeant Pharmaceuticals 41
6.3.1 Company Profile 41
6.3.2 Product Information 42
6.3.3 Sales, Price, Cost, Profit, and Revenue 42
6.4 Santen Pharma 43
6.4.1 Company Profile 43
6.4.2 Product Information 44
6.4.3 Sales, Price, Cost, Profit, and Revenue 44
6.5 Shire 45
6.5.1 Company Profile 45
6.5.2 Product Information 46
6.5.3 Sales, Price, Cost, Profit, and Revenue 46
6.6 Johnson & Johnson 47
6.6.1 Company Profile 47
6.6.2 Product Information 48
6.6.3 Sales, Price, Cost, Profit, and Revenue 48
6.7 United Laboratories 49
6.7.1 Company Profile 49
6.7.2 Product Information 50
6.7.3 Sales, Price, Cost, Profit, and Revenue 50
6.8 Senju Pharmaceutical 51
6.8.1 Company Profile 51
6.8.2 Product Information 52
6.8.3 Sales, Price, Cost, Profit, and Revenue 52
6.9 Jianfeng Group 53
6.9.1 Company Profile 53
6.9.2 Product Information 54
6.9.3 Sales, Price, Cost, Profit, and Revenue 54
6.10 Eusan GMBH 55
6.10.1 Company Profile 55
6.10.2 Product Information 56
6.10.3 Sales, Price, Cost, Profit, and Revenue 56
7 Dry Eye Drugs Manufacturing Cost Analysis 57
7.1 Dry Eye Drugs R&D Cost Analysis 57
7.1.1Clinical Phase Costs 58
7.1.2 Capitalized Costs 59
7.2 Proportion of Manufacturing Cost Structure 60
7.2.1 Raw Materials 60
7.2.2 Labor Cost 61
7.2.3 Other Costs Analysis 65
8 Industrial Chain, Sourcing Strategy and Downstream Buyers 71
8.1 Dry Eye Drugs Industrial Chain Analysis 71
8.2 Upstream Raw Materials Sourcing 72
8.3 Downstream Buyers 72
9 Marketing Strategy Analysis, Distributors/Traders 74
9.1 Marketing Channel 74
9.1.1 Direct Marketing 76
9.1.2 Indirect Marketing 76
9.1.3 Marketing Channel Development Trend 77
9.2 Market Positioning 78
9.2.1 Pricing Strategy 78
9.2.2 Brand Strategy 79
9.3 Distributors/Traders List 81
10 Factors Influencing 83
10.1 GDP for Major Regions 83
10.2 Population and Labor Considered for Forecast 85
10.3 Disposable Income Considered for Forecast 87
10.4 Environmental & Regulatory Trends 88
11 Global Dry Eye Drugs Market Forecast (2019-2025) 91
11.1 Global Dry Eye Drugs Sales, Revenue Forecast (2019-2025) 91
11.1.1 Global Dry Eye Drugs Sales and Growth Rate Forecast (2019-2025) 91
11.1.2 Global Dry Eye Drugs Revenue and Growth Rate Forecast (2019-2025) 92
11.2 Global Dry Eye Drugs Sales and Revenue Forecast by Regions (2019-2025) 92
11.2.1 North America Dry Eye Drugs Sales and Revenue Forecast (2019-2025) 94
11.2.2 Europe Dry Eye Drugs Sales and Revenue Forecast (2019-2025) 96
11.2.3 Asia-Pacific Dry Eye Drugs Sales and Revenue Forecast (2019-2025) 98
11.2.4 South America Dry Eye Drugs Sales and Revenue Forecast (2019-2025) 100
11.2.5 Middle East and Africa Dry Eye Drugs Sales and Revenue Forecast (2019-2025) 102
11.3 Global Dry Eye Drugs Sales, Revenue, Price Forecast by Type (2019-2025) 103
11.4 Global Dry Eye Drugs Sales Forecast by Application (2019-2025) 106
12 Research Findings and Conclusion 109
13 Methodology and Data Source 110
13.1 Methodology/Research Approach 110
13.1.1 Research Programs/Design 110
13.1.2 Market Size Estimation 111
1.3 Market Breakdown and Data Triangulation 112
13.2 Data Source 113
13.2.1 Secondary Sources 113
13.2.2 Primary Sources 114
13.3 Author List 115
13.4 Disclaimer 116

List of Tables

List of Tables and Figures

Figure Product Picture of Dry Eye Drugs 1
Table Global Dry Eye Drugs Sales (K Unit) Comparison by Types (2013-2025) 2
Figure Global Dry Eye Drugs Sales Market Share by Types in 2017 2
Figure Product Picture of Artificial Tears 3
Figure Product Picture of Anti-inflammatory drugs 3
Table Global Dry Eye Drugs Sales (K Unit) Comparison by Applications (2013-2025) 4
Figure Global Dry Eye Drugs Sales Market Share by Applications in 2017 4
Figure Hospital Examples 5
Figure Drug Stores Examples 5
Figure Online Pharmacies Examples 6
Table Global Market Dry Eye Drugs Revenue (M USD) Comparison by Regions 2013-2025 6
Figure North America Dry Eye Drugs Revenue (M USD) and Growth Rate (2013-2025) 7
Figure Europe Dry Eye Drugs Revenue (M USD) and Growth Rate (2013-2025) 8
Figure Asia-Pacific Dry Eye Drugs Revenue (M USD) and Growth Rate (2013-2025) 9
Figure South America Dry Eye Drugs Revenue (M USD) and Growth Rate (2013-2025) 10
Figure Middle East and Africa Dry Eye Drugs Revenue (M USD) and Growth Rate (2013-2025) 11
Figure Global Dry Eye Drugs Revenue (M USD) Status and Outlook (2013-2025) 12
Figure Global Dry Eye Drugs Sales (K Unit) Status and Outlook (2013-2025) 13
Table Global Dry Eye Drugs Sales (K Unit) of Key Manufacturers (2017-2018) 14
Table Global Dry Eye Drugs Sales Market Share by Manufacturers (2017-2018) 14
Figure 2017 Dry Eye Drugs Sales Market Share by Manufacturers 15
Figure 2018 Dry Eye Drugs Sales Market Share by Manufacturers 15
Table Global Dry Eye Drugs Revenue (M USD) by Manufacturers (2017-2018) 16
Table Global Dry Eye Drugs Revenue Market Share by Manufacturers (2017-2018) 16
Table 2017 Global Dry Eye Drugs Revenue Market Share by Manufacturers 17
Table 2018 Global Dry Eye Drugs Revenue Market Share by Manufacturers 17
Table Global Market Dry Eye Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2018) 18
Figure Global Market Dry Eye Drugs Average Price (USD/Unit) of Key Manufacturers in 2017 18
Table Manufacturers Dry Eye Drugs Headquarters and Established Date 19
Figure Dry Eye Drugs Sales Market Concentration Rate in 2017 20
Figure Dry Eye Drugs Revenue Market Share of Top 3 Manufacturers in 2017 21
Figure Dry Eye Drugs Revenue Market Share of Top 5 Manufacturers in 2017 21
Table Global Dry Eye Drugs Sales (K Unit) by Regions (2013-2018) 23
Table Global Dry Eye Drugs Sales Market Share by Regions (2013-2018) 23
Figure Global Dry Eye Drugs Sales Market Share by Regions (2013-2018) 24
Figure 2017 Global Dry Eye Drugs Sales Market Share by Regions 24
Table Global Dry Eye Drugs Revenue (M USD) by Regions (2013-2018) 25
Table Global Dry Eye Drugs Revenue Market Share by Regions (2013-2018) 25
Figure Global Dry Eye Drugs Revenue Market Share by Regions (2013-2018) 26
Figure 2017 Global Dry Eye Drugs Revenue Market Share by Regions 26
Table Global Dry Eye Drugs Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018) 27
Table North America Dry Eye Drugs Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018) 27
Table Europe Dry Eye Drugs Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018) 27
Table Asia-Pacific Dry Eye Drugs Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018) 28
Table South America Dry Eye Drugs Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018) 28
Table Middle East and Africa Dry Eye Drugs Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018) 28
Table Global Dry Eye Drugs Sales (K Unit) by Types (2013-2018) 29
Table Global Dry Eye Drugs Sales Market Share by Types (2013-2018) 29
Figure Sales Market Share of Dry Eye Drugs by Types (2013-2018) 30
Figure 2017 Sales Market Share of Dry Eye Drugs by Types 30
Table Global Dry Eye Drugs Revenue (M USD) by Types (2013-2018) 31
Table Global Dry Eye Drugs Revenue Market Share by Types (2013-2018) 31
Figure Revenue Market Share of Dry Eye Drugs by Types (2013-2018) 31
Figure 2017 Revenue Market Share of Dry Eye Drugs by Types 32
Table Global Dry Eye Drugs Price (USD/Unit) by Types (2013-2018) 32
Figure Global Dry Eye Drugs Sales Growth Rate by Type (2013-2018) 33
Table Global Dry Eye Drugs Sales (K Unit) by Applications (2013-2018) 34
Table Global Dry Eye Drugs Sales Market Share by Applications (2013-2018) 34
Figure Global Dry Eye Drugs Sales Market Share by Applications (2013-2018) 35
Figure Global Dry Eye Drugs Sales Market Share by Applications in 2017 35
Table Global Dry Eye Drugs Sales Growth Rate by Applications (2013-2018) 36
Figure Global Dry Eye Drugs Sales Growth Rate by Applications (2013-2018) 36
Table Allergan Company Profile 37
Figure Dry Eye Drugs Product Picture of Allergan 38
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of Allergan 2017-2018 38
Table Novartis AG Company Profile 39
Figure Dry Eye Drugs Product Picture of Novartis AG 40
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of Novartis AG 2017-2018 40
Table Valeant Pharmaceuticals Company Profile 41
Figure Dry Eye Drugs Product Picture of Valeant Pharmaceuticals 42
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of Valeant Pharmaceuticals 2017-2018 42
Table Santen Pharma Company Profile 43
Figure Dry Eye Drugs Product Picture of Santen Pharma 44
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of Santen Pharma 2017-2018 44
Table Shire Company Profile 45
Figure Dry Eye Drugs Product Picture of Shire 46
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of Shire 2017-2018 46
Table Johnson & Johnson Company Profile 47
Figure Dry Eye Drugs Product Picture of Johnson & Johnson 48
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2017-2018 48
Table United Laboratories Company Profile 49
Figure Dry Eye Drugs Product Picture of United Laboratories 50
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of United Laboratories 2017-2018 50
Table Senju Pharmaceutical Company Profile 51
Figure Dry Eye Drugs Product Picture of Senju Pharmaceutical 52
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of Senju Pharmaceutical 2017-2018 52
Table Jianfeng Group Company Profile 53
Figure Dry Eye Drugs Product Picture of Jianfeng Group 54
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of Jianfeng Group 2017-2018 54
Table Eusan GMBH Company Profile 55
Figure Dry Eye Drugs Product Picture of Eusan GMBH 56
Table Dry Eye Drugs Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Profit (USD/Unit), Revenue (M USD) and Gross Margin of Eusan GMBH 2017-2018 56
Figure typical phases from research to the market for a drug candidate 58
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound 59
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 60
Figure Manufacturing Cost Structure of Dry Eye Drugs 60
Figure USA Labor Cost Analysis 2013-2018 61
Figure Cost of Employing a Factory Worker 62
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe 63
Figure Monthly Minimum Wages in Asia 2016 64
Figure China Labor Costs 2013-2016 64
Table Average Price of Electricity to Ultimate Customers 2007-2016 65
Figure Electricity Prices for Household Consumers in 2016 67
Figure Summary of the Driving Assumptions 68
Figure Industrial Electric Rates 2016 (PER KWH) 69
Figure Dry Eye Drugs Industrial Chain Analysis 71
Figure Marketing Channel for Biopharmaceuticals 74
Figure Conceptual Model of the Flow of Products, Services and Funds for Non-specialty Drugs Coveredunder Private Insurance and Purchased in a Retail Setting 75
Figure Marketing Channel for Biopharmaceuticals 76
Figure Flow of US Prescription Sales Contribution by Channel 77
Figure Setting Pricing Policy 78
Table Distributors/Traders List 81
Figure GDP for Major Regions in 2016 83
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060 84
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 84
Figure Saving Rate Total, % of GDP, 2015 85
Figure Forecast of Global Middle-Class Population, 2015 to 2030 85
Figure Fertility Rates per Woman, 1970 to 2015 86
Figure Average Years of Schooling of the Adult Population 86
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016 87
Figure Household Spending Total, Million US dollars, 2015 87
Figure Net National Income Total, US dollars/capita, 2017 88
Figure Global Dry Eye Drugs Sales (K Unit) and Growth Rate Forecast (2019-2025) 91
Figure Global Dry Eye Drugs Revenue (M USD) and Growth Rate Forecast (2019-2025) 92
Table Global Dry Eye Drugs Sales (K Unit) Forecast by Regions (2019-2025) 92
Figure Global Dry Eye Drugs Sales Market Share Forecast by Regions (2019-2025) 93
Figure North America Dry Eye Drugs Sales (K Unit) and Growth Rate Forecast (2019-2025) 94
Figure North America Dry Eye Drugs Revenue (M USD) and Growth Rate Forecast (2019-2025) 95
Figure Europe Dry Eye Drugs Sales (K Unit) and Growth Rate Forecast (2019-2025) 96
Figure Europe Dry Eye Drugs Revenue (M USD) and Growth Rate Forecast (2019-2025) 97
Figure Asia-Pacific Dry Eye Drugs Sales (K Unit) and Growth Rate Forecast (2019-2025) 98
Figure Asia-Pacific Dry Eye Drugs Revenue (M USD) and Growth Rate Forecast (2019-2025) 99
Figure South America Dry Eye Drugs Sales (K Unit) and Growth Rate Forecast (2019-2025) 100
Figure South America Dry Eye Drugs Revenue (M USD) and Growth Rate Forecast (2019-2025) 101
Figure Middle East and Africa Dry Eye Drugs Sales (K Unit) and Growth Rate Forecast (2019-2025) 102
Figure Middle East and Africa Dry Eye Drugs Revenue (M USD) and Growth Rate Forecast (2019-2025) 103
Table Global Dry Eye Drugs Sales (K Unit) Forecast by Type (2019-2025) 103
Table Global Dry Eye Drugs Sales Market Share Forecast by Type (2019-2025) 103
Figure Global Dry Eye Drugs Sales Market Share Forecast by Type (2019-2025) 104
Figure Global Dry Eye Drugs Sales Market Share Forecast by Type in 2025 104
Table Global Dry Eye Drugs Revenue (M USD) Forecast by Type (2019-2025) 105
Table Global Dry Eye Drugs Revenue Market Share Forecast by Type (2019-2025) 105
Figure Global Dry Eye Drugs Revenue Market Share Forecast by Type (2019-2025) 105
Figure Global Dry Eye Drugs Revenue Market Share Forecast by Type in 2025 106
Table Global Dry Eye Drugs Price (USD/Unit) Forecast by Type (2019-2025) 106
Table Global Dry Eye Drugs Sales (K Unit) Forecast by Application (2019-2025) 106
Table Global Dry Eye Drugs Sales Forecast by Application (2019-2025) 107
Figure Global Dry Eye Drugs Sales Forecast by Application (2019-2025) 107
Figure Global Dry Eye Drugs Sales Forecast by Application in 2025 108

Latest News

09-Sep-2018

The microcrystalline cellulose (MCC) market size was estimated at USD 885.1 million in 2018

The microcrystalline cellulose (MCC) market size was estimated at USD 885.1 million in 2018 and is projected to reach USD 1,241.4 million by 2023, registering a CAGR of 7.0% from 2018 to 2023 ...

02-Feb-2018

The peracetic acid market size is estimated to be USD 664.9 million in 2018

The peracetic acid market size is estimated to be USD 664.9 million in 2018 and projected to reach USD 989.2 million by 2023, at a CAGR of 8.27%, from 2018 to 2023 ...

11-Nov-2017

The silicone elastomers market is projected to grow from USD 6.38 billion in 2017

The silicone elastomers market is projected to grow from USD 6.38 billion in 2017 to USD 8.81 billion by 2023, at a CAGR of 6.7% between 2017 and 2023 ...

10-Oct-2017

The market size of waste heat recovery system (WHRS) was USD 42.64 Billion in 2015

The market size of waste heat recovery system (WHRS) was USD 42.64 Billion in 2015 and is projected to reach USD 64.23 Billion by 2021, at a CAGR of 6.83% between 2016 and 2021 ...

09-Sep-2017

The global benzyl alcohol market was valued at US$196.21 mn in 2015

The global benzyl alcohol market was valued at US$196.21 mn in 2015 and is projected to reach US$297.72 mn by 2024, expanding at a CAGR of 4.67% therein ...